Evrima Technologies is a biotechnology and healthcare startup founded in 2019 with a mission to expedite clinical trial recruitment and advance medical research. The company's slogan, "Accelerating clinical trial recruitment to advance medical research and deliver new treatments to patients swiftly," encapsulates its primary objective.
The organization offers solutions for clinical trial recruitment to speed up research and provide new treatments to those in need. Its global impact on trial timelines has enabled rapid medical advancements and timely access to necessary therapies.
Evrima Technologies is dedicated to advancing medical development by accelerating patient identification and recruitment. By reducing the administrative workload on researchers, the company allows them to concentrate on the crucial clinical tasks essential for bringing new medicines from the lab to patients.
The company's last investment of $3.00M in a Seed Round took place on 05 September 2022. The investors involved in this round were Artesian, Wavemaker, and BridgeLane Capital.
This recent investment reflects the confidence of prominent investors in the potential of Evrima Technologies to make a significant impact in the biotechnology and healthcare industries through its innovative approach to clinical trial recruitment.
